欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/V/0288/001
药品名称Versican Plus BbPi IN
活性成分
    • bordetella bronchiseptica 8.0 CFU/ml
    • canine parainfluenza virus 3.5 CCID50
剂型Nasal drops, solution
上市许可持有人Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve Belgium
参考成员国 - 产品名称Germany (DE)
Versican Plus BbPi IN
互认成员国 - 产品名称
    • Belgium (BE)
      Versican Plus BbPi IN
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Versican Plus BbPi IN Nasentropfen, Lyophilisat und Lösungsmittel zur Herstellung einer Suspension für Hunde
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
      Biocan Novel Respi liofilizāts un šķīdinātājs suspensijas pilināšanai degunā pagatavošanai suņiem
    • Lithuania (LT)
      Biocan Novel Respi, nosies lašai, liofilizatas ir tirpiklis suspensijai ruošti šunims
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
      Biocan Novel Respi nosní kapky, lyofilizát a rozpouštědlo pro suspenzi pro psy
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2020/02/05
最近更新日期2024/01/19
药物ATC编码
    • QI07AF01 bordetella + canine parainfluenza virus
申请类型
  • TypeLevel1:non-food
  • TypeLevel2:Immunological
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase